quinazolines has been researched along with Carcinoma, Ehrlich Tumor in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aga, MA; Ali, S; Behl, A; Hamid, A; Hussain, A; Khan, S; Mondhe, DM; Qazi, AK; Saxena, AK; Shah, BA; Singh, SK; Taneja, SC | 1 |
Chuttani, K; Dhawan, D; Ghai, A; Kumar, P; Mishra, AK; Mittal, BR; Singh, B | 1 |
Gurubasavarajaswamy, PM; Nagaranavile, KS; Parameshwaran, T; Raghavendra, NM | 1 |
ISMAILOV, BI | 1 |
Abd Rabo, MM; El-Sayed Barakat, S; Ghorab, MM; Saker, HM | 1 |
Gurubasavarajaswamy, PM; Raghavendra, NM; Sriram, D; Thampi, P | 1 |
Grzelakowska-Sztabert, B; Sikora, F | 1 |
Danton, M; Flinn, N; Gibbons, WA; Hillery, AM; Toth, I; Wood, IP | 1 |
Donsback, RC; Sirotnak, FM | 1 |
9 other study(ies) available for quinazolines and Carcinoma, Ehrlich Tumor
Article | Year |
---|---|
Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Design; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Male; Membrane Potential, Mitochondrial; Mice; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden | 2015 |
Preclinical evaluation of (99m)Tc labeled gefitinib as a potential scintigraphic probe for the detection of tumors expressing epidermal growth factor receptors.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Contrast Media; ErbB Receptors; Gefitinib; Humans; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Molecular Probe Techniques; Molecular Probes; Quinazolines; Rabbits; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Technetium; Tissue Distribution | 2015 |
Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Topics: Acetamides; Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Hematologic Tests; Imidazoles; Lethal Dose 50; Mice; Quinazolines; Vincristine; Xenograft Model Antitumor Assays | 2009 |
[EFFECT OF SOME QUINAZOLINE DERIVATIVES ON TRANSPLANTABLE TUMORS].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Heterocyclic Compounds; Mercaptopurine; Mice; Pharmacology; Quinazolines; Rats; Research; Sarcoma 180 | 1964 |
Synthesis and antitumor activity of some novel quinazoline derivatives bearing the biologically active thione moiety.
Topics: Algorithms; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Survival; Chemical Phenomena; Chemistry, Physical; Doxorubicin; Indicators and Reagents; Quinazolines; Thiones | 2006 |
Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones.
Topics: Animals; Antineoplastic Agents; Antitubercular Agents; Carcinoma, Ehrlich Tumor; Drug Screening Assays, Antitumor; Furans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship | 2007 |
Quinazoline CB 3717 and CB 3703 inhibition of folate retention and metabolism in Ehrlich ascites carcinoma cells and some organs of the host-mouse.
Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Folic Acid; Folic Acid Antagonists; Kidney; Liver; Mice; Quinazolines | 1984 |
A lipidic alpha-amino acid based synthetic adjuvant peptide complex for increasing immunogenicity of vaccines.
Topics: Adjuvants, Immunologic; Administration, Oral; Amino Acid Sequence; Amino Acids; Animals; Carcinoma, Ehrlich Tumor; Gonadotropin-Releasing Hormone; Humans; Immunoglobulin G; Intestinal Absorption; Lipids; Mice; Molecular Sequence Data; Peptides; Quinazolines; Spectrometry, Mass, Fast Atom Bombardment; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1994 |
Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors.
Topics: Aminopterin; Animals; Aspartic Acid; Carcinoma, Ehrlich Tumor; Chick Embryo; DNA, Neoplasm; Folic Acid Antagonists; Intestine, Small; Leukemia L1210; Liver; Lymphoma; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Quinazolines; Sarcoma 180; Tetrahydrofolate Dehydrogenase; Time Factors | 1975 |